Epoch HealthNearly 90,000 Bottles of Children’s Ibuprofen Recalled Over ‘Black Particles,’ FDA Says

Nearly 90,000 bottles of Children’s Ibuprofen (100 mg/5 mL, 4 fl. oz.) manufactured by Strides Pharma for Taro Pharmaceuticals have been recalled after complaints of black particles and a gel-like mass in the product. The Class II recall covers lots 7261973A and 7261974A, expiring January 31, 2027, distributed to retailers nationwide.

Professional Impact

• A Class II classification indicates potential for temporary or reversible harm; serious adverse consequences are considered remote, but contamination origin remains undisclosed
• Strides Pharma received an FDA warning letter in 2019 for manufacturing control failures at its India facility, raising questions about quality oversight continuity
• Physicians and pharmacists may encounter families with recalled product at home; the FDA notice included no consumer guidance, creating a counseling gap
• No injury reports have been confirmed publicly, but the absence of a press release leaves clinicians without proactive notification through standard channels

Practice Applications

• Advise families to check lot numbers 7261973A and 7261974A on Children’s Ibuprofen bottles purchased recently
• Recommend discontinuing use of recalled product and contacting the dispensing pharmacy for guidance on return or replacement
• Consider alternative ibuprofen formulations or acetaminophen while families source unaffected product
• Monitor FDA recall database for updated consumer guidance, as none was included in the initial notice

More Product Recalls